Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Bariatric surgery980 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A23655 | 23594525 | Hum Hered | Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. | 2013 | Details |
A23669 | 23582557 | Rev Assoc Med Bras (1992) | [Nonalcoholic fatty liver disease and its association with metabolic syndrome in the preoperative period in patients undergoing bariatric surgery]. | 2013 | Details |
A23674 | 23576902 | ScientificWorldJournal | Current concepts and management approaches in nonalcoholic fatty liver disease. | 2013 | Details |
A23700 | 23555982 | PLoS One | Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. | 2013 | Details |
A23749 | 23512600 | Obesity (Silver Spring) | Serum hepcidin levels are associated with obesity but not liver disease. | 2013 | Details |
A23754 | 23509615 | J Obes | Platelet counts and liver enzymes after bariatric surgery. | 2013 | Details |
A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |
A23858 | 23424927 | Rev Prat | [Treatment of nonalcoholic steatohepatitis]. | 2012 | Details |
A23867 | 23418085 | Obesity (Silver Spring) | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. | 2013 | Details |
A23884 | 23404955 | Obesity (Silver Spring) | Alterations in adipocytokines and cGMP homeostasis in morbid obesity patients reverse after bariatric surgery. | 2013 | Details |
A23951 | 23355916 | World J Hepatol | Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. | 2012 | Details |
A24018 | 23299969 | Hepatology | Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. | 2013 | Details |
A24027 | 23294957 | Chirurgia (Bucur) | Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. | 2013 | Details |
A24113 | 23218652 | Gastroenterol Hepatol | [Acute liver failure after bariatric surgery. A case report and literature review]. | 2012 | Details |
A24156 | 23174488 | Clin Biochem | Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease. | 2012 | Details |
A24251 | 23075296 | Ital J Pediatr | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. | 2012 | Details |
A24422 | 22913901 | Postgrad Med | Managing diabetes in patients with chronic liver disease. | 2012 | Details |
A24426 | 22908056 | Hormones (Athens) | The pluses and minuses of bariatric surgery for morbid obesity: An endocrinological perspective. | 2013 | Details |
A24430 | 22902550 | J Hepatol | miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. | 2012 | Details |
A24436 | 22898488 | BMC Gastroenterol | The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. | 2012 | Details |
A24505 | 22824485 | Clin Liver Dis | Management of nonalcoholic steatohepatitis: an evidence-based approach. | 2012 | Details |
A24516 | 22821716 | Liver Transpl | Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation. | 2012 | Details |
A24518 | 22820478 | J Hepatol | Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. | 2012 | Details |
A24575 | 22735605 | Eur J Gastroenterol Hepatol | How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. | 2012 | Details |
A24587 | 22720278 | Can J Gastroenterol | Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2012 | Details |
A24598 | 22707395 | Hepatology | Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. | 2012 | Details |
A24652 | 22648049 | Eur Radiol | Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. | 2012 | Details |
A24685 | 22610995 | Obes Surg | Impact of weight-loss surgery and diabetes status on serum ALT levels. | 2012 | Details |
A24867 | 22418890 | Semin Liver Dis | The impact of bariatric surgery on nonalcoholic steatohepatitis. | 2012 | Details |
A24904 | 22375522 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and bariatric surgery. | 2012 | Details |
A24905 | 22374723 | Histol Histopathol | Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients. | 2012 | Details |
A24922 | 22359625 | PLoS One | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. | 2012 | Details |
A24927 | 22348916 | Drugs Today (Barc) | Current therapies for nonalcoholic fatty liver disease. | 2011 | Details |
A25063 | 24331173 | Obes Res Clin Pract | Hepatic tumor necrosis factor-α, leptin and adiponectin expression in morbid obese patients: Clinicopathological correlations. | 2013 | Details |
A25112 | 22161114 | Obes Surg | Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. | 2012 | Details |
A25148 | 22136330 | Liver Int | Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease. | 2011 | Details |
A25166 | 22119618 | Dig Liver Dis | N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis. | 2011 | Details |
A25183 | 22108808 | Obes Surg | Effect of bariatric surgery on liver fibrosis. | 2012 | Details |
A25198 | 22098270 | Liver Int | Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. | 2011 | Details |
A25339 | 21948267 | Obes Surg | Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. | 2011 | Details |
A25372 | 21911891 | Ann Hepatol | Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease. | 2011 | Details |
A25397 | 21893273 | Gastroenterol Clin North Am | Nonalcoholic fatty liver disease: pharmacologic and surgical options. | 2011 | Details |
A25529 | 21744131 | Obes Surg | Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. | 2011 | Details |
A25573 | 21703181 | J Hepatol | Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. | 2011 | Details |
A25648 | 21598007 | Obes Surg | Clinical predictors of different grades of nonalcoholic fatty liver disease. | 2012 | Details |
A25729 | 21499110 | Eur J Gastroenterol Hepatol | Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. | 2011 | Details |
A25750 | 21483633 | World J Gastroenterol | Intrahepatic natural killer T cell populations are increased in human hepatic steatosis. | 2011 | Details |
A25788 | 21455726 | Diabetologia | Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. | 2011 | Details |
A25825 | 21425426 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do. | 2011 | Details |
A25836 | 21412139 | Am J Med Sci | Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic. | 2011 | Details |
A25887 | 21352073 | Expert Opin Emerg Drugs | Treatment of non-alcoholic fatty liver disease with focus on emerging drugs. | 2011 | Details |
A25892 | 21348922 | Obes Rev | Cardiovascular benefits of bariatric surgery in morbidly obese patients. | 2011 | Details |
A25898 | 21345221 | Diabetol Metab Syndr | New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. | 2011 | Details |
A25905 | 21339203 | Gut | The role of apolipoprotein A5 in non-alcoholic fatty liver disease. | 2011 | Details |
A25980 | 21240660 | Obes Surg | Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1. | 2011 | Details |
A25996 | 21225497 | Pol J Pathol | Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. | 2010 | Details |
A26038 | 21180596 | Therap Adv Gastroenterol | Treatment options for nonalcoholic fatty liver disease. | 2010 | Details |
A26076 | 21145805 | J Hepatol | An apoptosis panel for nonalcoholic steatohepatitis diagnosis. | 2011 | Details |
A26105 | 21091931 | J Dig Dis | Epidemiology of the metabolic syndrome in the USA. | 2011 | Details |
A26129 | 21050233 | Aliment Pharmacol Ther | A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. | 2010 | Details |
A26171 | 20961734 | Nutrition | Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease. | 2010 | Details |
A26200 | 20922498 | Obes Surg | NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. | 2011 | Details |
A26247 | 20842181 | Nat Rev Endocrinol | Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. | 2010 | Details |
A26249 | 20842026 | Curr Opin Clin Nutr Metab Care | Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. | 2010 | Details |
A26364 | 20584230 | Int J Clin Pract | Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. | 2010 | Details |
A26383 | 20556538 | Obes Surg | Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence? | 2010 | Details |
A26404 | 23148155 | Ther Adv Endocrinol Metab | Advances in the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
A26422 | 20485253 | Minerva Gastroenterol Dietol | Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease. | 2010 | Details |
A26423 | 20485142 | Ann Surg | Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content. | 2010 | Details |
A26427 | 20473581 | Obes Surg | Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26435 | 20460923 | Dig Dis | Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. | 2010 | Details |
A26463 | 20448542 | Obesity (Silver Spring) | Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease. | 2010 | Details |
A26478 | 20415685 | Diabetes Obes Metab | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 | Details |
A26527 | 20361370 | Chirurg | [Indications and principles of metabolic surgery]. | 2010 | Details |
A26598 | 20119733 | Obes Surg | Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. | 2010 | Details |
A26614 | 20091629 | Cochrane Database Syst Rev | Bariatric surgery for non-alcoholic steatohepatitis in obese patients. | 2010 | Details |
A26628 | 20066503 | Obes Surg | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. | 2010 | Details |
A26659 | 20033348 | Obes Surg | SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. | 2009 | Details |
A26746 | 19845871 | Obes Rev | Non-alcoholic fatty liver disease from pathogenesis to management: an update. | 2009 | Details |
A26760 | 19818313 | Clin Liver Dis | Non-alcoholic fatty liver disease: is bariatric surgery the answer? | 2009 | Details |
A26818 | 19727004 | J Clin Gastroenterol | Effect of weight loss on nonalcoholic fatty liver disease. | 2010 | Details |
A26830 | 19693638 | Obes Surg | Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery. | 2009 | Details |
A26848 | 19664840 | J Hepatol | Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. | 2009 | Details |
A26893 | 19573756 | Semin Pediatr Surg | Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. | 2009 | Details |
A26911 | 19381126 | Ann Hepatol | Is exercise an effective treatment for NASH? Knowns and unknowns. | 2009 | Details |
A26912 | 19381125 | Ann Hepatol | Treatment regimens for non-alcoholic fatty liver disease. | 2009 | Details |
A26985 | 19409898 | Gastroenterology | Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. | 2009 | Details |
A26989 | 19396962 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2009 | Details |
A27009 | 19360015 | Obesity (Silver Spring) | Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. | 2009 | Details |
A27033 | 19301078 | Obes Surg | Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis. | 2009 | Details |
A27096 | 19194305 | Eur J Gastroenterol Hepatol | Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. | 2009 | Details |
A27142 | 19098851 | Am J Gastroenterol | The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. | 2009 | Details |
A27146 | 19087776 | Cir Esp | [Prevalence and associated factors to non-alcoholic steatohepatitis in obese patients subjected to bariatric surgery]. | 2008 | Details |
A27163 | 19065650 | Hepatology | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. | 2009 | Details |
A27177 | 19034237 | Ann Hepatol | Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery. | 2009 | Details |
A27201 | 18995215 | Clin Gastroenterol Hepatol | Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. | 2008 | Details |
A27206 | 18986848 | Clin Gastroenterol Hepatol | Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. | 2008 | Details |
A27216 | 18956298 | Semin Liver Dis | Effects of weight loss on nonalcoholic fatty liver disease. | 2008 | Details |
A27217 | 18956297 | Semin Liver Dis | Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. | 2008 | Details |
A27218 | 18956296 | Semin Liver Dis | Current and emerging therapies in nonalcoholic fatty liver disease. | 2008 | Details |